期刊文献+

多囊卵巢综合征患者血清中血管生成素相关生长因子水平的评价 被引量:2

An appraisal of serum angiopoientin related growth factor in PCOS
原文传递
导出
摘要 目的探讨多囊卵巢综合征(PCOS)患者血清中血管生成素相关生长因子(angiopoientin-related growth factor,AGF)水平变化,及AGF与PCOS患者胰岛素抵抗的关系。方法 2010年3月至2011年3月在沧州市中心医院选择67例未合并糖尿病的PCOS患者作为研究组,同期选择112例健康女性作为对照组,测定所有研究对象血清AGF质量浓度及与胰岛素抵抗相关的内分泌代谢指标。结果研究组血清AGF水平显著高于对照组(345.3±38.6)vs.(288.7±33.4)μg/L,P<0.05;PCOS胰岛素抵抗组血清AGF水平显著高于PCOS非胰岛素抵抗组(350.9±29.6)vs.(338.4±31.6)μg/L,P<0.05。AGF与BMI(r=0.23,P<0.05)、胰岛素抵抗(IR)指数(HOMA-IR)(r=0.19,P<0.05)呈正相关,与年龄、低密度脂蛋白(LDL-C)、腰臀比(WHR)、空腹血糖(FBG)、2h糖耐量试验(OGTT)、空腹胰岛素(FINS)无关。结论升高的AGF可能在PCOS患者糖脂代谢紊乱的发生发展过程中发挥作用。 Objective To evaluate the plasma angiopoientin related growth factor level changes in PCOS patients and its relationship with insulin resistance. Methods we chose 67 PCOS patients as the experimental group and 112 non-PCOS subjects as the control group since March 2010 to March 2011 in the contral Hospital of Cangzbou City. Then we measured the plasma AGF level and endocrine indexes. Results Plasma AGF level in PCOS group is significantly higher than control group(345.3 38.6 vs 288.7 33.4, P 〈0. 05), and insulin-resistant PCOS group is also higher than insulin-resistant PCOS group(350. 9 29. 6 vs 338. 4 -+31.6, P 〈0.05). Fasting plasma AGF level correlated negatively with BMI (r = -0. 23, P 〈0. 05) ,HOMA-IR(r = -0. 19, P 〈0. 05). Conclusion evaluated AGF may play a potential role in the disorder of glucose and lipid metabolism in PCOS patients.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2012年第9期706-708,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 多囊卵巢综合征 胰岛素 polycystic ovarian syndrome insulin
  • 相关文献

参考文献9

  • 1Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus[J]. Fertil Steril, 2002, 77 (6) : 1095-1105.
  • 2Oike Y, Akao M, Yasunaga K, et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance[J]. Nat Med ,2005,11 (4) :400-408.
  • 3Namkung J,Baek SK,Kong D, et al. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome [ J]. Metabolism Clinical and Experimental, 2011,60(4) :564- 568.
  • 4RotterdamESHRE/ASRM-Sponsored PCOS Consensus Workshop Group:revised 2003 consensus on diagnostic criteria and lung- term health risks related to polycystic ovary syndrome[J]. Fertil Steril,2004,81 ( 1 ) : 19-25.
  • 5杨文英,杨兆军,李光伟,邢小燕.联合测量腰臀围比值(或腰围)和血压可预测代谢综合征[J].中华内分泌代谢杂志,2005,21(3):227-229. 被引量:92
  • 6Boztosun A, Deveci K, Klcl F, et al. Serum levels of angiopoietin-related growth factor (AGF) are increased in polycystic ovary syndrome[J]. J lnvestig Med, 2012, 8 (10) :201-203.
  • 7Oike Y, Tabata M, Angiopoietin-like proteins-potential therapeutic targets for metabolic syndrome and cardiovascular disease[ J]. Circ J, 2009, 73(12) :2192-2197.
  • 8Namkung J, Koh SB, Kong ID,et al. Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome [J]. Metabolism, 2011,60(4):564-568.
  • 9石建霞,邹大进.单纯性肥胖患者血管形成素相关生长因子的表达及意义[J].第二军医大学学报,2011,32(1):37-39. 被引量:1

二级参考文献18

  • 1Fasshauer M, Paschke R. Regulation of adipocytokines and in sulin resistance[J].Diahetologia, 2003,46 : 1594 -1603.
  • 2Hotamisligil G S,Shargill N S, Spiegelman B M. Adipose ex pression of tumor necrosis factor -alpa: direct role in obesity linked insulin resistance[J]. Science, 1993,259 : 87 -91.
  • 3Kharitonenkov A, Shiyanova T I., Koester A, Ford A M, Micanovic R, Galbreath E J, et al. FGF-21 as a novel metabolic regulator[J].J Clin Invest, 2005,115: 1627-1635.
  • 4Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, Ito Y, et al. Angiopoietin related growth factor antagonizes obesity and insulin resistance[J]. Nat Med,2005,11:400- 408.
  • 5Oike Y, Yasunaga K, Ito Y, Matsumoto S, Maekawa H, Morisada T, et al. Angiopoietin related growth factor (AGE) pro motes epidermal proliferation, remodeling, and regeneration [J]. Proe Natl Acad Sci USA, 2003,100:9494-9499.
  • 6Kersten S. Regulation of lipid metabolism via angiopoietin like proteins[J]. Biochem Soc Trans,2005,33 : 1059 -1062.
  • 7Oike Y, Akao M, Kubota Y, Suda T. Angiopoietin like pro teins: potential new targets for metabolic syndrome therapy[J]. Trends Mol Med,2005,11:473- 479.
  • 8George J. Angiopoietin like proteins: another player in the metabolic field[J].J Hepatol,2006,44:832- 834.
  • 9Ebert T, Baehmanna A, Lossner U, Kratzsch J, Bluher M, Stumvoll M,et al. Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis[J]. Metabolism, 2009,58 : 547-551.
  • 10Namkung J,Koh S B,Kong I D,Choi J W,Yeh B I. Serum levels of angiopoietin related growth factor are increased in metabolic syndrome[J]. Metabolism, 2010[Epub ahead of print].

共引文献91

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部